Dechra Pharmaceuticals to acquire Piedmont Animal Health for $210m.

Synopsis

Dechra Pharmaceuticals, a developer of veterinary products, agreed to acquire Piedmont Animal Health, an animal veterinary pharmaceutical company, for $210m.

Principals

target

Pidemonth Animal Health

bidder

Dechra Pharmaceuticals

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (2)

michael f. kelly

COO at PIDEMONTH ANIMAL HEALTH

Manager

target

Deal

£ 175 M

Total Value

roland johnson

Founder and CEO at PIDEMONTH ANIMAL HEALTH

Manager

target

Deal

£ 175 M

Total Value

Bidder Team (2)

ian page

CEO at DECHRA PHARMACEUTICALS PLC

Manager

bidder

Deals

£ 5.52 B

Total Value

paul sandland

CFO at DECHRA PHARMACEUTICALS PLC

Manager

bidder

Deals

£ 5.48 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy